Supplemental material
Expert Opinion on Drug Delivery
Volume 16, 2019 - Issue 9
Original Research
An evaluation of the use and handling errors of currently available recombinant human follicle-stimulating hormone pen injectors by women with infertility and fertility nurses
, , , , & 
Thomas D’HoogheGlobal Medical Affairs Fertility, Merck KGaA, Darmstadt, Germany;Department of Development and Regeneration, University of Leuven, Leuven, Belgium;Department of Obstetrics and Gynecology, Yale University, New Haven, USACorrespondence[email protected]
https://orcid.org/0000-0002-2373-8257View further author information
https://orcid.org/0000-0002-2373-8257View further author informationRelated Research Data
An evaluation of the use and handling errors of currently available recombinant human follicle-stimulating hormone pen injectors by women with infertility and fertility nurses
Source:
Taylor & Francis
An evaluation of the use and handling errors of currently available recombinant human follicle-stimulating hormone pen injectors by women with infertility and fertility nurses
Source:
Taylor & Francis
An evaluation of the use and handling errors of currently available recombinant human follicle-stimulating hormone pen injectors by women with infertility and fertility nurses
Source:
Taylor & Francis
Linking provided by
